Enlong Ma
Key Laboratory Of Structure Based Drug Design & Discovery Of Ministry Of Education, 103 Wenhua Road, Shenhe District
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Discovery of novel selective HDAC6 inhibitors via a scaffold hopping approach for the treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo.
Journal: Bioorganic chemistry
Published: January 22, 2025
Correlation between allergy and cancer: a systematic review and meta-analysis.
Journal: Scientific reports
Published: December 23, 2024
Design, synthesis, and biological evaluation of novel 3-naphthylthiophene derivatives as potent SIRT2 inhibitors for the treatment of myocardial fibrosis.
Journal: Bioorganic chemistry
Published: November 06, 2024
Discovery of novel pyrrolo[2,1-c][1,4]benzodiazepine-3,11-dione (PBD) derivatives as selective HDAC6 inhibitors for the efficient treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo.
Journal: European journal of medicinal chemistry
Published: April 15, 2024
Screening approach by a combination of computational and in vitro experiments: identification of fluvastatin sodium as a potential SIRT2 inhibitor.
Journal: Journal of molecular modeling
Published: November 22, 2023
Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1.
Journal: Bioorganic chemistry
Published: November 14, 2023
Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.
Journal: Bioorganic & medicinal chemistry letters
Published: July 16, 2022
Structural and PK-guided identification of indole-based non-acidic autotaxin (ATX) inhibitors exhibiting high in vivo anti-fibrosis efficacy in rodent model.
Journal: European journal of medicinal chemistry
Published: September 24, 2021
Human Glioma Cells Therapy Using ATRA-Induced Differentiation Method to Promote the Inhibitive Effect of TMZ and CCDP.
Journal: Journal of healthcare engineering
Published: August 25, 2021
Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
Journal: Bioorganic chemistry
Published: May 25, 2021
ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.
Journal: Chemico-biological interactions
Published: May 20, 2021
Last Updated: 09/26/2026